Drug reference
rosiglitazone
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Endocrine (Insulin sensitizers)
Mechanism of action
Lowers glucose by improving target cell response to insulin without increasing pancreatic cell secretion; activates nuclear peroxisome proliferator-activated receptor gamma, which influences the production of gene products involved in glucose and lipid metabolism
Common side effects
- Edema
- Increased LDL-cholesterol
- Hypertension
- Increased HDL-cholesterol
- Increased total cholesterol
- Heart failure/congestive heart failure
- Myocardial ischemia
Related conditions
Frequently asked questions
What drug class is rosiglitazone?
rosiglitazone belongs to: Endocrine.
How does rosiglitazone work?
Lowers glucose by improving target cell response to insulin without increasing pancreatic cell secretion; activates nuclear peroxisome proliferator-activated receptor gamma, which influences the production of gene products involved in glucose and lipid metabolism
What are the common side effects of rosiglitazone?
Edema, Increased LDL-cholesterol, Hypertension, Increased HDL-cholesterol, Increased total cholesterol, Heart failure/congestive heart failure, Myocardial ischemia
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.